Loading…

Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells

Rhabdomyosarcoma is the most common soft tissue sarcoma in the pediatric population. As this tumor has an undifferentiated myogenic phenotype, agents that promote differentiation hold particular promise as part of a novel therapeutic approach to combat this type of cancer. In this report, we focus o...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2010-09, Vol.24 (9), p.3427-3437
Main Authors: Rao, Prakash K, Missiaglia, Edoardo, Shields, Lauren, Hyde, Greg, Yuan, Bingbing, Shepherd, Christopher J, Shipley, Janet, Lodish, Harvey F
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303
cites cdi_FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303
container_end_page 3437
container_issue 9
container_start_page 3427
container_title The FASEB journal
container_volume 24
creator Rao, Prakash K
Missiaglia, Edoardo
Shields, Lauren
Hyde, Greg
Yuan, Bingbing
Shepherd, Christopher J
Shipley, Janet
Lodish, Harvey F
description Rhabdomyosarcoma is the most common soft tissue sarcoma in the pediatric population. As this tumor has an undifferentiated myogenic phenotype, agents that promote differentiation hold particular promise as part of a novel therapeutic approach to combat this type of cancer. In this report, we focus on the contribution of two microRNAs (miRNAs) in rhabdomyosarcomas. Levels of miR-1 and miR-133a are drastically reduced in representative cell lines from each major rhabdomyosarcoma subtype (embryonal and alveolar). Introduction of miR-1 and miR-133a into an embryonal rhabdomyosarcoma-derived cell line is cytostatic, thereby suggesting a tumor suppressor-like role for these myogenic miRNAs. Transcriptional profiling of cells after miR-1 and miR-133a expression reveals that miR-1 (but not miR-133a) exerts a strong promyogenic influence on these poorly differentiated tumor cells. We identify mRNAs that are down-regulated by these miRNAs and propose roles for miR-1 and miR-133a in repressing isoforms of genes that are normally not expressed in muscle. Finally, we show that mRNA targets of miR-1 and miR-133a are up-regulated in rhabdomyosarcomas, suggesting a causative role for these miRNAs in the development of rhabdomyosarcomas. More important, these results point to the promise of enhancing rhabdomyosarcoma therapy using miRNAs as agents that mediate cytostasis and promote muscle differentiation.--Rao, P. K., Missiaglia, E., Shields, L., Hyde, G., Yuan, B., Shepherd, C. J., Shipley, J., Lodish, H. F. Distinct roles for Mir-1 and Mir-133a in the proliferation and differentiation of rhabdomyosarcoma cells.
doi_str_mv 10.1096/fj.09-150698
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3231107</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>754000599</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303</originalsourceid><addsrcrecordid>eNp9kc1v1DAQxa0K1G4Xbj0X37g0ZWwnjn1BgpblQ5WQaDlbs7Hd9SqJFzvbav_7ZklZwYWTx57fvHnWI-SMwSUDLd_59SXoglUgtToiM1YJKKSS8ILMQGleSCnUCTnNeQ0ADJg8JiccSilVrWZkdR3yEPpmoCm2LlMfE-3Cj4JR7O1UCYE09HRYOboZoeBdwiHE_jdhgx_vrh_C9BY9TStc2tjtYsbUxA5p49o2vyIvPbbZvX4-5-Ru8enu6ktx8_3z16sPN0VTca4KIaQWNa8FCMdL9DWrqxKEXmLNZFlrV4ISlldcoPe11Qwbq731nlnYD83J-0l2s112zjajs4St2aTQYdqZiMH82-nDytzHByO4YGyUmJO3zwIp_tq6PJgu5P0PsHdxm83eDkCl9UheTGSTYs7J-cMWBmYfjfFrA9pM0Yz4-d_ODvCfLEZATcBjaN3uv2JmcfuRL76BPmi_mUY9RoP3KWTz85YDE8CUKrXi4glfhaQP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>754000599</pqid></control><display><type>article</type><title>Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Rao, Prakash K ; Missiaglia, Edoardo ; Shields, Lauren ; Hyde, Greg ; Yuan, Bingbing ; Shepherd, Christopher J ; Shipley, Janet ; Lodish, Harvey F</creator><creatorcontrib>Rao, Prakash K ; Missiaglia, Edoardo ; Shields, Lauren ; Hyde, Greg ; Yuan, Bingbing ; Shepherd, Christopher J ; Shipley, Janet ; Lodish, Harvey F</creatorcontrib><description>Rhabdomyosarcoma is the most common soft tissue sarcoma in the pediatric population. As this tumor has an undifferentiated myogenic phenotype, agents that promote differentiation hold particular promise as part of a novel therapeutic approach to combat this type of cancer. In this report, we focus on the contribution of two microRNAs (miRNAs) in rhabdomyosarcomas. Levels of miR-1 and miR-133a are drastically reduced in representative cell lines from each major rhabdomyosarcoma subtype (embryonal and alveolar). Introduction of miR-1 and miR-133a into an embryonal rhabdomyosarcoma-derived cell line is cytostatic, thereby suggesting a tumor suppressor-like role for these myogenic miRNAs. Transcriptional profiling of cells after miR-1 and miR-133a expression reveals that miR-1 (but not miR-133a) exerts a strong promyogenic influence on these poorly differentiated tumor cells. We identify mRNAs that are down-regulated by these miRNAs and propose roles for miR-1 and miR-133a in repressing isoforms of genes that are normally not expressed in muscle. Finally, we show that mRNA targets of miR-1 and miR-133a are up-regulated in rhabdomyosarcomas, suggesting a causative role for these miRNAs in the development of rhabdomyosarcomas. More important, these results point to the promise of enhancing rhabdomyosarcoma therapy using miRNAs as agents that mediate cytostasis and promote muscle differentiation.--Rao, P. K., Missiaglia, E., Shields, L., Hyde, G., Yuan, B., Shepherd, C. J., Shipley, J., Lodish, H. F. Distinct roles for Mir-1 and Mir-133a in the proliferation and differentiation of rhabdomyosarcoma cells.</description><identifier>ISSN: 0892-6638</identifier><identifier>EISSN: 1530-6860</identifier><identifier>DOI: 10.1096/fj.09-150698</identifier><identifier>PMID: 20466878</identifier><language>eng</language><publisher>United States: The Federation of American Societies for Experimental Biology</publisher><subject>Cell Differentiation - genetics ; Cell Line, Tumor ; Cell Proliferation ; Gene Expression Profiling ; Humans ; microRNA ; MicroRNAs - genetics ; MicroRNAs - metabolism ; muscle ; Research Communications ; Rhabdomyosarcoma - genetics ; Rhabdomyosarcoma - pathology ; tumor</subject><ispartof>The FASEB journal, 2010-09, Vol.24 (9), p.3427-3437</ispartof><rights>FASEB</rights><rights>2010 FASEB 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303</citedby><cites>FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20466878$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rao, Prakash K</creatorcontrib><creatorcontrib>Missiaglia, Edoardo</creatorcontrib><creatorcontrib>Shields, Lauren</creatorcontrib><creatorcontrib>Hyde, Greg</creatorcontrib><creatorcontrib>Yuan, Bingbing</creatorcontrib><creatorcontrib>Shepherd, Christopher J</creatorcontrib><creatorcontrib>Shipley, Janet</creatorcontrib><creatorcontrib>Lodish, Harvey F</creatorcontrib><title>Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><description>Rhabdomyosarcoma is the most common soft tissue sarcoma in the pediatric population. As this tumor has an undifferentiated myogenic phenotype, agents that promote differentiation hold particular promise as part of a novel therapeutic approach to combat this type of cancer. In this report, we focus on the contribution of two microRNAs (miRNAs) in rhabdomyosarcomas. Levels of miR-1 and miR-133a are drastically reduced in representative cell lines from each major rhabdomyosarcoma subtype (embryonal and alveolar). Introduction of miR-1 and miR-133a into an embryonal rhabdomyosarcoma-derived cell line is cytostatic, thereby suggesting a tumor suppressor-like role for these myogenic miRNAs. Transcriptional profiling of cells after miR-1 and miR-133a expression reveals that miR-1 (but not miR-133a) exerts a strong promyogenic influence on these poorly differentiated tumor cells. We identify mRNAs that are down-regulated by these miRNAs and propose roles for miR-1 and miR-133a in repressing isoforms of genes that are normally not expressed in muscle. Finally, we show that mRNA targets of miR-1 and miR-133a are up-regulated in rhabdomyosarcomas, suggesting a causative role for these miRNAs in the development of rhabdomyosarcomas. More important, these results point to the promise of enhancing rhabdomyosarcoma therapy using miRNAs as agents that mediate cytostasis and promote muscle differentiation.--Rao, P. K., Missiaglia, E., Shields, L., Hyde, G., Yuan, B., Shepherd, C. J., Shipley, J., Lodish, H. F. Distinct roles for Mir-1 and Mir-133a in the proliferation and differentiation of rhabdomyosarcoma cells.</description><subject>Cell Differentiation - genetics</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Gene Expression Profiling</subject><subject>Humans</subject><subject>microRNA</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>muscle</subject><subject>Research Communications</subject><subject>Rhabdomyosarcoma - genetics</subject><subject>Rhabdomyosarcoma - pathology</subject><subject>tumor</subject><issn>0892-6638</issn><issn>1530-6860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kc1v1DAQxa0K1G4Xbj0X37g0ZWwnjn1BgpblQ5WQaDlbs7Hd9SqJFzvbav_7ZklZwYWTx57fvHnWI-SMwSUDLd_59SXoglUgtToiM1YJKKSS8ILMQGleSCnUCTnNeQ0ADJg8JiccSilVrWZkdR3yEPpmoCm2LlMfE-3Cj4JR7O1UCYE09HRYOboZoeBdwiHE_jdhgx_vrh_C9BY9TStc2tjtYsbUxA5p49o2vyIvPbbZvX4-5-Ru8enu6ktx8_3z16sPN0VTca4KIaQWNa8FCMdL9DWrqxKEXmLNZFlrV4ISlldcoPe11Qwbq731nlnYD83J-0l2s112zjajs4St2aTQYdqZiMH82-nDytzHByO4YGyUmJO3zwIp_tq6PJgu5P0PsHdxm83eDkCl9UheTGSTYs7J-cMWBmYfjfFrA9pM0Yz4-d_ODvCfLEZATcBjaN3uv2JmcfuRL76BPmi_mUY9RoP3KWTz85YDE8CUKrXi4glfhaQP</recordid><startdate>201009</startdate><enddate>201009</enddate><creator>Rao, Prakash K</creator><creator>Missiaglia, Edoardo</creator><creator>Shields, Lauren</creator><creator>Hyde, Greg</creator><creator>Yuan, Bingbing</creator><creator>Shepherd, Christopher J</creator><creator>Shipley, Janet</creator><creator>Lodish, Harvey F</creator><general>The Federation of American Societies for Experimental Biology</general><general>Federation of American Societies for Experimental Biology</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201009</creationdate><title>Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells</title><author>Rao, Prakash K ; Missiaglia, Edoardo ; Shields, Lauren ; Hyde, Greg ; Yuan, Bingbing ; Shepherd, Christopher J ; Shipley, Janet ; Lodish, Harvey F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Cell Differentiation - genetics</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Gene Expression Profiling</topic><topic>Humans</topic><topic>microRNA</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>muscle</topic><topic>Research Communications</topic><topic>Rhabdomyosarcoma - genetics</topic><topic>Rhabdomyosarcoma - pathology</topic><topic>tumor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rao, Prakash K</creatorcontrib><creatorcontrib>Missiaglia, Edoardo</creatorcontrib><creatorcontrib>Shields, Lauren</creatorcontrib><creatorcontrib>Hyde, Greg</creatorcontrib><creatorcontrib>Yuan, Bingbing</creatorcontrib><creatorcontrib>Shepherd, Christopher J</creatorcontrib><creatorcontrib>Shipley, Janet</creatorcontrib><creatorcontrib>Lodish, Harvey F</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rao, Prakash K</au><au>Missiaglia, Edoardo</au><au>Shields, Lauren</au><au>Hyde, Greg</au><au>Yuan, Bingbing</au><au>Shepherd, Christopher J</au><au>Shipley, Janet</au><au>Lodish, Harvey F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>2010-09</date><risdate>2010</risdate><volume>24</volume><issue>9</issue><spage>3427</spage><epage>3437</epage><pages>3427-3437</pages><issn>0892-6638</issn><eissn>1530-6860</eissn><abstract>Rhabdomyosarcoma is the most common soft tissue sarcoma in the pediatric population. As this tumor has an undifferentiated myogenic phenotype, agents that promote differentiation hold particular promise as part of a novel therapeutic approach to combat this type of cancer. In this report, we focus on the contribution of two microRNAs (miRNAs) in rhabdomyosarcomas. Levels of miR-1 and miR-133a are drastically reduced in representative cell lines from each major rhabdomyosarcoma subtype (embryonal and alveolar). Introduction of miR-1 and miR-133a into an embryonal rhabdomyosarcoma-derived cell line is cytostatic, thereby suggesting a tumor suppressor-like role for these myogenic miRNAs. Transcriptional profiling of cells after miR-1 and miR-133a expression reveals that miR-1 (but not miR-133a) exerts a strong promyogenic influence on these poorly differentiated tumor cells. We identify mRNAs that are down-regulated by these miRNAs and propose roles for miR-1 and miR-133a in repressing isoforms of genes that are normally not expressed in muscle. Finally, we show that mRNA targets of miR-1 and miR-133a are up-regulated in rhabdomyosarcomas, suggesting a causative role for these miRNAs in the development of rhabdomyosarcomas. More important, these results point to the promise of enhancing rhabdomyosarcoma therapy using miRNAs as agents that mediate cytostasis and promote muscle differentiation.--Rao, P. K., Missiaglia, E., Shields, L., Hyde, G., Yuan, B., Shepherd, C. J., Shipley, J., Lodish, H. F. Distinct roles for Mir-1 and Mir-133a in the proliferation and differentiation of rhabdomyosarcoma cells.</abstract><cop>United States</cop><pub>The Federation of American Societies for Experimental Biology</pub><pmid>20466878</pmid><doi>10.1096/fj.09-150698</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0892-6638
ispartof The FASEB journal, 2010-09, Vol.24 (9), p.3427-3437
issn 0892-6638
1530-6860
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3231107
source Wiley-Blackwell Read & Publish Collection
subjects Cell Differentiation - genetics
Cell Line, Tumor
Cell Proliferation
Gene Expression Profiling
Humans
microRNA
MicroRNAs - genetics
MicroRNAs - metabolism
muscle
Research Communications
Rhabdomyosarcoma - genetics
Rhabdomyosarcoma - pathology
tumor
title Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T23%3A33%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Distinct%20roles%20for%20miR-1%20and%20miR-133a%20in%20the%20proliferation%20and%20differentiation%20of%20rhabdomyosarcoma%20cells&rft.jtitle=The%20FASEB%20journal&rft.au=Rao,%20Prakash%20K&rft.date=2010-09&rft.volume=24&rft.issue=9&rft.spage=3427&rft.epage=3437&rft.pages=3427-3437&rft.issn=0892-6638&rft.eissn=1530-6860&rft_id=info:doi/10.1096/fj.09-150698&rft_dat=%3Cproquest_pubme%3E754000599%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=754000599&rft_id=info:pmid/20466878&rfr_iscdi=true